Results 311 to 320 of about 108,133 (341)

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Glucagon-Like Peptide-1 Receptor Agonist Treatment for Pediatric Obesity

2015
Obesity is a complex and retractable disease for which effective and durable treatments are elusive. Successful treatment of severe obesity with lifestyle modification therapy alone is highly unlikely, particularly for adolescents. Pharmacotherapy, if appropriately prescribed, can be an effective tool to use in conjunction with lifestyle modification ...
openaire   +2 more sources

Glucagon-like Peptide-1 Receptor Agonists (GLP1-RA)

2022
Radica Z. Alicic, Emily J. Cox, Joshua J. Neumiller, Katherine R. Tuttle   +3 more
openaire   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists—How Safe Are They?

JAMA Internal Medicine, 2022
Shanzay, Haider, Kasia J, Lipska
openaire   +2 more sources

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis.

Metabolism: Clinical and Experimental
P. Karakasis, Dimitrios Patoulias, N. Fragakis, Christos S. Mantzoros   +3 more
semanticscholar   +1 more source

[Glucagon-like peptide-1 receptor agonists].

Nihon rinsho. Japanese journal of clinical medicine, 2012
Takeshi, Kurose, Yutaka, Seino
openaire   +1 more source

Breast cancer statistics, 2019

Ca-A Cancer Journal for Clinicians, 2019
Carol E Desantis, Jiemin, Mia M Gaudet
exaly  

Glucagon-Like Peptide 1 Receptor Agonist Use Before Surgery

JAMA Surgery
Philip M, Jones, Ion A, Hobai
openaire   +2 more sources